本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexeo Therapeutics

5.88
+0.12502.17%
成交量:35.13万
成交额:199.71万
市值:4.29亿
市盈率:-2.35
高:5.88
开:5.66
低:5.51
收:5.76
52周最高:10.99
52周最低:1.45
股本:7,298.73万
流通股本:4,500.50万
量比:0.45
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-2.5000
每股收益(LYR):-3.0934
净资产收益率:-80.69%
总资产收益率:-44.66%
市净率:3.55
市盈率(LYR):-1.90

数据加载中...

2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/27

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities